Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
112.81 USD195.22 USD263.63 USD
-52.63%
195.22 USDCurrent price is 52.6% below the base model value.
A
HealthcareMedical DevicesUnited States
ABT.US · Abbott Laboratories
NYQ · US · USD
Latest price92.48 USD
30D+18.49%
Vs. base value+72.5%
Research summary
ABT.US latest organized financial period shows revenue grew +5.67% YoY and net income declined -51.32% YoY. Current price is about 92.48 USD, while the model base case is about 53.61 USD; the current price sits +72.5% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue44B USD
Net income7B USD
Free cash flow7B USD
Operating cash flow10B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:23
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price92.48 USD
Base value53.61 USD
Vs. base+72.5%
Price date2026/04/28
55.61 USD53.61 USD60.88 USD
+72.51%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
61.33 USD57.33 USD71.88 USD
+61.31%
57.33 USDCurrent price is 61.3% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth6.2%
Current price implies roughly 6.2% annualized FCF growth.
6.2%Current price implies roughly 6.2% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
35.63 USD35.63 USD35.63 USD
+160%
35.63 USDCurrent price is 159.6% above the base model value.
Updated: 2026/04/29 07:23
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 9
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | 44B USD | 7B USD | 7B USD | 3.72 |
| 2024/12/30 | Annual | 42B USD | 13B USD | 6B USD | 7.64 |
| 2023/12/30 | Annual | 40B USD | 6B USD | 5B USD | 3.26 |
| 2022/12/30 | Annual | 44B USD | 7B USD | 8B USD | 3.91 |
| 2021/12/30 | Annual | - | - | - | - |
Ad placement